April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Ocular Distribution and Spectrum of Activity of a Fully Human Anti-Herpes Simplex Virus IgG Fab Fragment, Following Topical Application
Author Affiliations & Notes
  • M. Berdugo-Polak
    INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
    Pierre et Marie Curie University, Paris 6, Paris, France
  • I. V. Larsen
    Department of Ophthalmology and Visual Sciences,
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • C. Abadie
    ribOvax Biotechnologies, Petit-Lancy, Switzerland
  • L. Kowalczuk
    INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
    Pierre et Marie Curie University, Paris 6, Paris, France
  • E. Touchard
    INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
    Pierre et Marie Curie University, Paris 6, Paris, France
  • J. D. Nelson
    Calmune Corporation, San Diego, California
  • P. P. Elena
    Iris Pharma, La Gaude, France
  • C. R. Brandt
    Department of Ophthalmology and Visual Sciences,
    Department of Medical Microbiology and Immunology,
    University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  • F. Behar-Cohen
    INSERM UMRS 872, Les Cordeliers,, Paris Descartes University, Paris, France
    Pierre et Marie Curie University, Paris 6, Paris, France
    Hotel-Dieu University Hospital, Paris, France
  • J.-M. Combette
    ribOvax Biotechnologies, Petit-Lancy, Switzerland
  • Footnotes
    Commercial Relationships  M. Berdugo-Polak, None; I.V. Larsen, None; C. Abadie, ribOvax Biotechnologies, E; L. Kowalczuk, None; E. Touchard, None; J.D. Nelson, Calmune Corporation, E; P.P. Elena, Iris Pharma, I; C.R. Brandt, None; F. Behar-Cohen, None; J.-M. Combette, ribOvax Biotechnologies, E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1991. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Berdugo-Polak, I. V. Larsen, C. Abadie, L. Kowalczuk, E. Touchard, J. D. Nelson, P. P. Elena, C. R. Brandt, F. Behar-Cohen, J.-M. Combette; Ocular Distribution and Spectrum of Activity of a Fully Human Anti-Herpes Simplex Virus IgG Fab Fragment, Following Topical Application. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1991.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate ocular biodistribution of an anti-HSV human IgG Fab fragment (AC-8, 53 kDa), following topical administration onto the rat eye, and to determine the spectrum of activity against HSV-1 ocular isolates.

Methods: : An AC-8 solution (10-1000 µg/mL) was instilled 5 times/day for 1-4 days on rat eyes with normal or de-epithelialized corneas. At 1, 6, and 24 hours after administration, the eyes were processed for either IHC or ELISA assay. Antiviral activity was determined for 13 HSV strains using a yield reduction assay.

Results: : After repeated instillation, AC-8 was found in the corneal epithelium, anterior stroma, sub-epithelial stromal cells and retinal glial cells. The AC-8 signal was more intense at the limbus and peripheral cornea suggesting a trans-limbal and trans-scleral intraocular penetration. De-epithelialization did not change the AC-8 distribution profile but the newly-formed epithelium was intensely labeled. Sub-conjunctival injection resulted in a much higher AC-8 signal in the anterior segment and retina. Using either instillation of AC-8 or sub-conjunctival injection, levels consistent with anti-viral activity were found in the corneal epithelium. The EC50 values ranged from 0.01 to 0.04 µg/mL.

Conclusions: : Topical instillation of an anti-HSV Fab can be used on intact and ulcerated cornea. It does not alter re-epithelialization. The intracellular uptake and broad inhibition suggests that AC-8 could feasibly exert a protection against HSV ocular infection.

Keywords: antiviral drugs • herpes simplex virus • pathology: experimental 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×